Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes. Biomarkers could facilitate the prioritisation of patients for genetic testing. We hypothesised that patients with different underlying genetic aetiologies for their diabetes could have distinct ...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 182.3KB)
- Publisher copy:
- Local pid:
- Deposit date:
- Copyright holder:
- Gloyn et al
- Copyright date:
- Copyright Gloyn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record